Chrysophsin-1

General Information


DRACP ID  DRACP00497

Peptide Name   Chrysophsin-1

Sequence  FFGWLIKGAIHAGKAIHGLIHRRRH

Sequence Length  25

UniProt ID  Not available

PubChem CID  Not available

Origin  Red sea bream

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
DU145 Prostate carcinoma Carcinoma ~87%Inhibit=5 µg/mL MTS assay 24 h 1
DU145 Prostate carcinoma Carcinoma ~87%Inhibit=5 µg/mL MTS assay 24 h 1
DU145 Prostate carcinoma Carcinoma ~87%Inhibit=5 µg/mL MTS assay 24 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  NIH3T3: ~35%Inhibit=5 µg/mL; WS-1: ~42%Inhibit=5 µg/mL

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00497

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C136H211N45O26

Absent amino acids  CDEMNPQSTVY

Common amino acids  GHI

Mass  332075

Pl  12.81

Basic residues  9

Acidic residues  0

Hydrophobic residues  12

Net charge  9

Boman Index  -2750

Hydrophobicity  0

Aliphatic Index  105.6

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  5500

Absorbance 280nm  229.17

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 21349308

Title  Characteristics of the antitumor activities in tumor cells and modulation of the inflammatory response in RAW264.7 cells of a novel antimicrobial peptide, chrysophsin-1, from the red sea bream (Chrysophrys major)

Doi 10.1016/j.peptides.2011.02.013

Year  2011

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.